Discovery of Potent Tetrazole Free Fatty Acid Receptor 2 Antagonists

被引：2
|
作者：
Valentini, Alice [3 ]
Schultz-Knudsen, Katrine [3 ]
Hansen, Anders Hojgaard [2 ]
Tsakoumagkou, Argyro [3 ]
Jenkins, Laura [1 ]
Christensen, Henriette B. [2 ]
Manandhar, Asmita [3 ]
Milligan, Graeme [1 ]
Ulven, Trond [2 ,3 ]
Ulven, Elisabeth Rexen [3 ]
机构：
[1] Univ Glasgow, Coll Med Vet & Life Sci, Ctr Translat Pharmacol, Sch Mol Biosci, Glasgow G12 8QQ, Scotland
[2] Univ Southern Denmark, Dept Phys Chem & Pharm, DK-5230 Odense M, Denmark
[3] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2023年 / 66卷 / 09期
基金：
英国生物技术与生命科学研究理事会;
关键词：
FFA2; ANTAGONIST; FUNCTIONAL-CHARACTERIZATION; GLUCOSE-TOLERANCE; GUT MICROBIOTA; DIETARY FIBER; AGONIST; GPR43; IDENTIFICATION; GLPG0974; SAFETY;
D O I：
10.1021/acs.jmedchem.2c01935
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The free fatty acid receptor 2 (FFA2), also known as GPR43, mediates effects of short-chain fatty acids and has attracted interest as a potential target for treatment of various metabolic and inflammatory diseases. Herein, we report the results from bioisosteric replacement of the carboxylic acid group of the established FFA2 antagonist CATPB and SAR investigations around these compounds, leading to the discovery of the first high potency FFA2 antagonists, with the preferred compound TUG 2304 (16l) featuring IC50 values of 3-4 nM in both cAMP and GTP gamma S assays, favorable physicochemical and pharmacokinetic properties, and the ability to completely inhibit propionate induced neutrophil migration and respiratory burst.
引用
收藏
页码：6105 / 6121
页数：17
相关论文
共 50 条
  • [21] Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists
    Cherney, Robert J.
    Brogan, John B.
    Mo, Ruowei
    Lo, Yvonne C.
    Yang, Gengjie
    Miller, Persymphonie B.
    Scherle, Peggy A.
    Molino, Bruce F.
    Carter, Percy H.
    Decicco, Carl P.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 597 - 601
  • [22] Discovery of Potent Competitive Antagonists and Positive Modulators of the P2X2 Receptor
    Baqi, Younis
    Hausmann, Ralf
    Rosefort, Christiane
    Rettinger, Juergen
    Schmalzing, Guenther
    Mueller, Christa E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (03) : 817 - 830
  • [23] Discovery and characterization of novel highly potent A2A adenosine receptor antagonists for cancerimmunotherapy
    Lee, Kyungik
    Jun, Seungah
    Byun, EunYoung
    Lee, Hosun
    Lee, Yongtaek
    Moon, MiJin
    Kim, Yu-Yon
    Kang, Hyun Jeong
    Ahn, YoungGil
    Kim, YoungHoon
    Suh, Kwee Hyun
    CANCER RESEARCH, 2019, 79 (13)
  • [24] Discovery of potent cyclic pseudopeptide human tachykinin NK-2 receptor antagonists
    Giannotti, D
    Perrotta, E
    Di Bugno, C
    Nannicini, R
    Harmat, NJS
    Giolitti, A
    Patacchini, R
    Renzetti, AR
    Rotondaro, L
    Giuliani, S
    Altamura, M
    Maggi, CA
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (22) : 4041 - 4044
  • [25] The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonists
    Porter, David W.
    Bradley, Michelle
    Brown, Zarin
    Canova, Riccardo
    Charlton, Steven
    Cox, Brian
    Hunt, Peter
    Kolarik, David
    Lewis, Sarah
    O'Connor, Des
    Reilly, John
    Spanka, Carsten
    Tedaldi, Lauren
    Watson, Simon J.
    Wermuth, Roland
    Press, Neil J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (01) : 72 - 76
  • [26] Discovery of spiropiperidine-based potent and selective Orexin-2 receptor antagonists
    Fujimoto, Tatsuhiko
    Tomata, Yoshihide
    Kunitomo, Jun
    Hirozane, Mariko
    Marui, Shogo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (21) : 6409 - 6413
  • [27] Development of prostaglandin D2 receptor antagonist:: discovery of highly potent antagonists
    Torisu, K
    Kobayashi, K
    Iwahashi, M
    Nakai, Y
    Onoda, T
    Nagase, T
    Sugimoto, I
    Okada, Y
    Matsumoto, R
    Nanbu, F
    Ohuchida, S
    Nakai, H
    Toda, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (17) : 4685 - 4700
  • [28] Discovery of potent free fatty acid receptor 1 full agonists with a novel scaffold bearing conjugated double bond linker
    Yang, Ziwei
    Sun, Jun
    Xu, Tifei
    Wang, Yu
    Fang, Jiahui
    Wang, Kai
    Guo, Shimeng
    Xie, Xin
    Shen, Jianhua
    BIOORGANIC & MEDICINAL CHEMISTRY, 2025, 123
  • [29] Discovery of novel pyrrole-based scaffold as potent and orally bioavailable free fatty acid receptor 1 agonists for the treatment of type 2 diabetes
    Li, Zheng
    Pan, Miaobo
    Su, Xin
    Dai, Yuxuan
    Fu, Mian
    Cai, Xingguang
    Shi, Wei
    Huang, Wenlong
    Qian, Hai
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (09) : 1981 - 1987
  • [30] Discovery of Betulinic Acid Derivatives as Potent Intestinal Farnesoid X Receptor Antagonists to Ameliorate Nonalcoholic Steatohepatitis
    Zhang, Chenlu
    Liu, Yameng
    Wang, Ying
    Ge, Xie
    Jiao, Tingying
    Yin, Jianpeng
    Wang, Kanglong
    Li, Cuina
    Guo, Shimeng
    Xie, Xin
    Xie, Cen
    Nan, Fajun
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (19) : 13452 - 13472
12345